drugset / Trial / NCT01248104

Comparison of Tranexamic to Epsilon Aminocaproic Acid: a Prospective Analysis of Blood Conservation in Cardiac Surgery

NCT01248104

Completed 100 enrolled Loma Linda University
RandomizedParallel-groupTriple-blindTreatment

Summary

We designed a prospective double-blinded randomized trial in an attempt to detect a difference between tranexamic acid (TXA) and epsilon aminocaproic acid (EACA) in reducing transfusion in patients undergoing cardiac surgery.

Timeline

Start
2010-03
Primary completion
2013-03
Completion
2015-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aminocaproic Acid Small molecule 10 mg/kg
Comparator Tranexamic Acid Small molecule 1 mg/kg

Indications

No indication recorded.